Global Immunocytokines Market Size
Market Size in USD Mn
CAGR40.3%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 40.3% |
| Market Concentration | High |
| Major Players | IOVance Biotherapeutics, Inc., Bluebird bio, Bellicum Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Juno Therapeutics, Inc. and Among Others |
please let us know !
Global Immunocytokines Market Analysis
The Global Immunocytokines Market is estimated to be valued at USD 971.0 million in 2025 and is expected to reach USD 10390.2 million by 2032, growing at a compound annual growth rate (CAGR) of 40.3% from 2025 to 2032.
The immunocytokines market is expected to witness a positive growth trend over the forecast period. The increasing applications of immunocytokines in various therapeutic areas including oncology, autoimmune disorders and infectious diseases is expected to drive the demand. In addition, the rising investments by key players for research and development of novel and effective fusion proteins is also anticipated to contribute to the market growth. However, factors such as high costs associated with production complexities and large-scale manufacturing of immunocytokines may hamper the overall industry expansion to some extent during the analysis period.